Calithera Biosciences, Inc.

CALA · OTC
Analyze with AI
12/31/2022
9/30/2022
6/30/2022
3/31/2022
Operating Activities
Net Income-$7-$10-$9-$14
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1$1$1
Change in WC-$3$0-$1-$4
Other Non-Cash$0$0-$2$0
Operating Cash Flow-$9-$8-$11-$16
Investing Activities
PP&E Inv.-$0$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$0-$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$8$0$8$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$8$1
Forex Effect$0$0$0$0
Net Chg. in Cash-$9-$8-$3-$15
Supplemental Information
Beg. Cash$34$42$45$60
End Cash$26$34$42$45
Free Cash Flow-$9-$8-$11-$16
Calithera Biosciences, Inc. (CALA) Financial Statements & Key Stats | AlphaPilot